Dr. R.S.Gupta Diagnostics And Hospitals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.20 M
About Dr. R.S.Gupta Diagnostics And Hospitals
Dr. R.S.Gupta Diagnostics And Hospitals Private Limited (DRDAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 May 1996 and has a history of 28 years and eight months. Its registered office is in Uttar Pradesh, Uttar Pradesh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.20 M.
Ritu Gupta, Madhu Gupta, and Arpan Gupta serve as directors at the Company.
Company Details
- Location Uttar Pradesh, Uttar Pradesh
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85110UP1996PTC020049
- Company No.
020049
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 May 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Dr. R.S.Gupta Diagnostics And Hospitals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ritu Gupta  | Director | 31-May-1996 | Current |
| Madhu Gupta | Director | 31-May-1996 | Current |
| Arpan Gupta | Additional Director | 17-Aug-2020 | Current |
Financial Performance of Dr. R.S.Gupta Diagnostics And Hospitals.
Dr. R.S.Gupta Diagnostics And Hospitals Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr. R.S.Gupta Diagnostics And Hospitals?
In 2017, Dr. R.S.Gupta Diagnostics And Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.20 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.72 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2020 | Axis Bank Limited | ₹7.20 M | Open |
How Many Employees Work at Dr. R.S.Gupta Diagnostics And Hospitals?
Unlock and access historical data on people associated with Dr. R.S.Gupta Diagnostics And Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. R.S.Gupta Diagnostics And Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. R.S.Gupta Diagnostics And Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
